Evidence map›Paper›PMID 32685384›Full record

ArticleBiotechnology reports (Amsterdam, Netherlands)2020

Peter Elias Kidibule, Paloma Santos-Moriano, Francisco Jose Plou, María Fernández-Lobato

Open access · goldAbstract read
In one paragraph

Article in Biotechnology reports (Amsterdam, Netherlands), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Saudi journal of biological sciences · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Structure-Function Insights into the FungalInternational journal of molecular sciences · 2022
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Peter Elias KidibuleDepartment of Molecular Biology, Centre for Molecular Biology Severo Ochoa (CSIC-UAM), University Autonomous from Madrid. Nicolás Cabrera, 1. Cantoblanco. 28049 Madrid, Spain.
Paloma Santos-MorianoInstitute of Catalysis and Petrochemistry, CSIC. Marie Curie, 2. Cantoblanco, 28049 Madrid, Spain.
Francisco Jose PlouInstitute of Catalysis and Petrochemistry, CSIC. Marie Curie, 2. Cantoblanco, 28049 Madrid, Spain.
María Fernández-LobatoDepartment of Molecular Biology, Centre for Molecular Biology Severo Ochoa (CSIC-UAM), University Autonomous from Madrid. Nicolás Cabrera, 1. Cantoblanco. 28049 Madrid, Spain.
Instituto de Catálisis y Petroleoquímica · ESUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biological activity of chitooligosaccharides (COS) has made them targets for industrial and medical sectors. In this work,

Indexed as

Bioactive chito-oligomersChitinChitosanCOS, chitooligosaccharidesDD, degree of deacetylationDP, degree of polymerizationFRAP, Ferric Reducing Antioxidant PowerGH, Glycoside HydrolaseGlcNAc, N-Acetyl-d-glucosamineGlcN, D-glucosamineHeterologous expressionpaCOS, partially acetylated COSPichia pastorisRSA, Radical Scavenging Activity

Identifiers

PMID32685384
PMCPMC7355052
OpenAlexW3038802120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.